They aim to deliver better medicines to patients by predicting, with greater accuracy and earlier, which paths are more likely to lead to successful treatments. By integrating machine learning and modern biological tools at scale, insitro is able to train truly enabling predictive models that outperform intuition. Their team consists of scientists, engineers, and drug hunters who collaborate across disciplines to generate and leverage data to advance tomorrow's medicines.

While they don't expect machine learning to be the solution to all R&D problems, they believe it's time to bring new and powerful tools to the process of discovering and developing new drugs. As a truly data-driven company, insitro aims to reshape the future of drug discovery and development